In a report released today, Ronald Kamdem from Morgan Stanley maintained a Buy rating on Healthpeak Properties (DOC – Research Report), with a price target of $24.00. The company’s shares ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback